1/ We recently confirmed the effectiveness of the Pfizer-BioNTech vaccine outside of randomized trials @NEJM. nejm.org/doi/full/10.10…
Studies like ours are being used to promote a vaccine passport to travel in the US, UK, and European Union.
A few clarifications are in order.
2/
Before we start, a disclaimer:
Vaccine passports involve complex ethical, economic, and political considerations.
Here I talk exclusively about scientific issues. The goal is that those making decisions have a better understanding of what we do and do not know as of today.
3/ Based on our study, we can say confidently that the vaccine is highly effective in preventing you from getting sick with #COVID19.
Based on our study, we can't say confidently that the vaccine is highly effective in preventing you from getting infected and infecting others.
4/ Why?
Because our study was designed to estimate vaccine effectiveness to prevent infections DOCUMENTED by the health system, not ALL infections.
Documented infections are predominantly symptomatic, so our study shows effectiveness to prevent symptomatic (and severe) disease.
5/ Why did we choose DOCUMENTED infections rather than ALL infections?
Individuals with symptoms tend to seek diagnostic testing so their infections get documented. Therefore, our study is expected to include most symptomatic infections and essentially all severe infections.
6/
In contrast, many asymptomatic individuals and some with very mild symptoms never get detected by the health system.
Therefore, we couldn't investigate ALL infections because we didn't have a full sample of all infections. Not even a random sample.
Having said this...
7/
... in a secondary analysis, we used our imperfect ascertainment of asymptomatic #COVID19.
Our estimates were consistent with high effectiveness to prevent asymptomatic infection but, given the data limitations, we'll have to wait for better studies. nejm.org/doi/suppl/10.1…
8/ Of course it makes sense that vaccines help prevent infections, not only disease. If only because, by reducing the risk of symptomatic disease, vaccines shorten the time during which infected individuals can infect, as well as their viral loads.
But more evidence is needed.
9/ Back to the vaccine passport. This is what science knows today:
Vaccines prevent most travelers from getting symptomatic #COVID19, but we still don't know how much vaccines protect others from being infected by travelers.
A lesser issue after vaccinating all willing adults.
• • •
Missing some Tweet in this thread? You can try to
force a refresh
2/ Porque las cifras oficiales cuentan como UCI cualquier cama donde se puede instalar un respirador:
quirófanos, salas reanimación postquirúrgica, unidad coronaria, UCI pediátrica...
Y no cuentan que el 70-75% de UCIs de verdad suelen están ocupadas en periodos no pandémicos.
3/ Así que el número de personas ingresadas en UCI por #COVID19 en Madrid es mayor que el número de camas reales de UCI en cada hospital.
Por ejemplo:
"La Paz" tiene 30 camas de UCI y 31 ingresados por COVID-19
"12 de Octubre" tiene 24 camas de UCI y 34
ingresados pr COVID-19
New York and Madrid had similar epidemics until they spectacularly diverged.
In March, both cities were caught by surprise and shut down because of #COVID19.
In September, the situation is under control in NY and alarming in Madrid.
Why?
2/ Let’s start with the similarities: two big, dense cities with a large network of public transit and lots of visitors.
An explosive outbreak of #SARSCOV2 overwhelmed their contact tracing system and their hospitals. A lockdown was required to reduce the public health disaster.
3/ By June, both places had succeeded in bringing down the number of new cases. That's precisely what lockdowns do.
In July, new cases started to increase in Madrid until reaching one of the highest incidences in Europe.
New York has not seen any increase in new cases yet.
2/ No country has explicitly adopted a #stratifiedlockdown, but many have implicitly defaulted into some version of it.
That is, governments haven't ordered older people and their cohabitants to stay home, but they do recommend those in vulnerable groups to be extremely careful.
3/ As a result:
Many older people have chosen to live in a soft lockdown: no venturing into public spaces unless strictly necessary, few visits with relatives, regular use of face masks.
Many young people, feeling at low risk, have reverted to pre-pandemic social interactions.